Catherine (Cate) Hankins
A community medicine specialist, Professor Hankins’ current scientific interests include COVID-19 immunity, novel biomedical HIV prevention, participatory research conduct, and scientific knowledge translation and communication. She was principal investigator of ‘The Canadian Women’s HIV Study’, studies involving prisoners and people who inject drugs, evaluation studies, and population-based epidemiological studies before joining the UN. Chief Scientific Adviser to UNAIDS in Geneva from 2002 for a decade, she led the scientific knowledge translation team focused on ensuring ethical and participatory HIV prevention trial conduct, convening mathematical modelling teams, and supporting country implementation of proven biomedical HIV prevention modalities. She led the development of Good Participatory Practice Guidelines for trials of Emerging Pathogens for the World Health Organization in 2016. She chairs the Scientific Advisory Committee of the European and Developing Countries Clinical Trials Partnership (EDCTP) and the Scientific Advisory Group of the US National Institutes of Health (NIH) HIV Prevention Trials Network (HPTN). She is a trustee of the HIV Research Trust and a member of the International AIDS Society Industry Liaison Forum. She is a Senior Fellow at the Amsterdam Institute for Global Health and Development (AIGHD), University of Amsterdam, the Netherlands and Honorary Professor, Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, England. Keenly interested in scientific capacity development and advancing women in global health and science, Professor Hankins was the Scientific Chair of the annual African INTEREST conferences on HIV treatment, pathogenesis, and prevention research in resource-limited settings (2015 Harare, Zimbabwe; 2016 Yaoundé, Cameroon; 2017 Lilongwe, Malawi; 2018 Kigali, Rwanda; 2019 Accra, Ghana; 2020 Windhoek, Namibia). , She is Co-Chair of the Eastern Europe and Central Asia INTERACT Workshop (2019 Almaty, Kazakhstan; 2021 virtual). She was the Scientific Programme Chair of the Tenth EDCTP Forum 2021 (Maputo, Mozambique). She is the AIGHD lead on the CAPRISA trials in South Africa of HIV pre-exposure prophylaxis (CAP018 implant and CAP012 combination monoclonal antibodies). She was named to the Order of Canada in 2013.
COVID-19: immunity, epidemiology, public health, policy HIV: biomedical prevention
Biomedical HIV prevention, pre-exposure prophylaxis, HIV and women COVID-19 seroprevalence, immunity